Former Allscripts CEO lands $52M in startup funding

Livongo, a Mountain View, Calif.-based diabetes management startup, raised an additional $52.5 million in funding, according to Chicago Inno.

Livongo — led by CEO Glen Tullman, former CEO of Allscripts — offers a blood glucose monitor, which connects to a digital dashboard for real-time health information. Its goal is to help diabetes patients manage their care.

This most recent funding round was co-led by General Catalyst and Kinnevik. Other investors included Singapore-based EDBI, American Investment Holdings and Microsoft Ventures.

The startup, which has raised more than $143 million since its launch in 2014, plans to expand into other chronic condition management services with this new funding. It will also begin distribution into international markets.

More articles on health IT:
Penn Medicine sets sights on Yelp, Twitter data to drive better patient care
GAO: Patients aren't viewing their health data
UCLA develops AI chatbot for radiology care

© Copyright ASC COMMUNICATIONS 2019. Interested in LINKING to or REPRINTING this content? View our policies by clicking here.

 

Top 40 Articles from the Past 6 Months